Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet K Samur

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Nucleic Acids Research|May 31, 2012
Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancersZhenyu Yan, Parantu K Shah, Samir B Amin, et al.
Nature Communications|May 2, 2018
Widespread intronic polyadenylation diversifies immune cell transcriptomesIrtisha Singh, Shih-Han Lee, Adam S Sperling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple MyelomaKeiji Kurata, Mehmet K Samur, Priscilla Liow, et al.
Blood|November 21, 2024
Development of hyperdiploidy starts at an early age and takes a decade to completeMehmet K Samur, Anil Aktas Samur, Parth Shah, et al.
Blood|November 22, 2023
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myelomaSubodh Kumar, Srikanth Talluri, Jiangning Zhao, et al.
Blood Cancer Journal|December 19, 2022
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factorsAnil Aktas Samur, Mariateresa Fulciniti, Herve Avet-Loiseau, et al.
Communications Biology|May 25, 2021
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinomaSubodh Kumar, Leutz Buon, Srikanth Talluri, et al.
Blood|March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple MyelomaChandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
Cell Reports|December 28, 2018
Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple MyelomaMariateresa Fulciniti, Charles Y Lin, Mehmet K Samur, et al.
Blood|January 11, 2023
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myelomaTing Du, Yan Song, Arghya Ray, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Nucleic Acids Research|May 31, 2012
Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancersZhenyu Yan, Parantu K Shah, Samir B Amin, et al.
Nature Communications|May 2, 2018
Widespread intronic polyadenylation diversifies immune cell transcriptomesIrtisha Singh, Shih-Han Lee, Adam S Sperling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple MyelomaKeiji Kurata, Mehmet K Samur, Priscilla Liow, et al.
Blood|November 21, 2024
Development of hyperdiploidy starts at an early age and takes a decade to completeMehmet K Samur, Anil Aktas Samur, Parth Shah, et al.
Blood|November 22, 2023
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myelomaSubodh Kumar, Srikanth Talluri, Jiangning Zhao, et al.
Blood Cancer Journal|December 19, 2022
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factorsAnil Aktas Samur, Mariateresa Fulciniti, Herve Avet-Loiseau, et al.
Communications Biology|May 25, 2021
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinomaSubodh Kumar, Leutz Buon, Srikanth Talluri, et al.
Blood|March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple MyelomaChandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
Cell Reports|December 28, 2018
Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple MyelomaMariateresa Fulciniti, Charles Y Lin, Mehmet K Samur, et al.
Blood|January 11, 2023
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myelomaTing Du, Yan Song, Arghya Ray, et al.
Pageof 5